Here, we reported for the first time that PLA2G16 was expressed at a higher level in human osteosarcoma patients with metastasis compared with non-metastatic patients and that the positive PLA2G16 expression in osteosarcoma tissues was significantly correlated with metastatic features and with shorter OS and MFS times. Here, PLAAT3 is linked to osteosarcoma.